STAT5B and ovarian carcinoma: To extend the above findings that specific shRNAs against RELA and STAT5B effectively sensitized chemoresistant ovarian cancer cells to carboplatin killing, we sought to determine the effect of their small molecule inhibitors as potential chemosensitizers.